Both in Pharmaceuticals
Bicara Therapeutics vs Cronos Group Inc. Common Share
Over the past year BCAX returned +33.8% and CRON returned +13.8%; their daily moves had a correlation of 0.11.
BCAX +33.8% CRON +13.8%Growth of $1, one year, split-adjusted
| Metric | BCAX | CRON |
|---|---|---|
| Price | $18.56 | $3.38 |
| Market cap | $1.23B | $1.25B |
| Today | −1.28% | −0.88% |
| 1 month | −20.8% | 0.0% |
| 6 months | −2.5% | +38.5% |
| Year to date | +10.3% | +28.5% |
| 1 year | +58.5% | +28.5% |
| Revenue growth (YoY) | — | +59.5% |
| Gross margin | — | 65.8% |
| Net margin | — | 45.4% |
| P/E (TTM) | — | 17.8× |
| Price / sales | — | 4.8× |
| Net cash | $497.3M | $797.0M |
| Dividend yield | — | — |
| Volatility (60d) | 56.5% | 37.4% |
| Short % of float | 22.1% | 1.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).